Evidence on the efficacy of ivermectin for COVID-19: another story of apples and oranges

Affiliations

¹ Department of Anaesthesiology, Intensive Care, Emergency and Pain Medicine, University Hospital Wurzburg, Wurzburg, Bayern, Germany.
² Institute of General Practice, Heinrich-Heine-Universitat Dusseldorf, Dusseldorf, Germany.
³ Evidence-Based Oncology, Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
⁴ Department of Infectious Diseases and Respiratory Medicine, Humboldt-Universitat zu Berlin, Berlin, Germany.
⁵ Department of Anaesthesiology, Intensive Care, Emergency and Pain Medicine, University Hospital Wurzburg, Wurzburg, Bayern, Germany weibel_s@ukw.de.

Maria Popp et al. BMJ Evid Based Med. 2022 Jun.

. 2022 Jun;27(3):187-188.

doi: 10.1136/bmjebm-2021-111791. Epub 2021 Aug 20.

¹ Department of Anaesthesiology, Intensive Care, Emergency and Pain Medicine, University Hospital Wurzburg, Wurzburg, Bayern, Germany.
² Institute of General Practice, Heinrich-Heine-Universitat Dusseldorf, Dusseldorf, Germany.
³ Evidence-Based Oncology, Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
⁴ Department of Infectious Diseases and Respiratory Medicine, Humboldt-Universitat zu Berlin, Berlin, Germany.
⁵ Department of Anaesthesiology, Intensive Care, Emergency and Pain Medicine, University Hospital Wurzburg, Wurzburg, Bayern, Germany weibel_s@ukw.de.

No abstract available

Keywords: COVID-19; emergency medicine; evidence-based practice; general practice; infectious disease medicine.

Conflict of interest statement

Competing interests: The authors authored the Cochrane Review on ivermectin for preventing and treating COVID‐19.

1. Garegnani LI, Madrid E, Meza N. Misleading clinical evidence and systematic reviews on ivermectin for COVID-19. BMJ Evid Based Med 2022;27:156–8. 10.1136/bmjebm-2021-111678 - DOI - PubMed
1. Bryant A, Lawrie TA, Dowswell T, et al. . Ivermectin for prevention and treatment of COVID-19 infection: a systematic review, meta-analysis, and trial sequential analysis to inform clinical guidelines. Am J Ther 2021;28:e434–60. 10.1097/MJT.0000000000001402 - DOI - PMC - PubMed
1. Popp M, Stegemann M, Metzendorf M-I, et al. . Ivermectin for preventing and treating COVID-19. Cochrane Database Syst Rev 2021;7:CD015017. 10.1002/14651858.CD015017.pub2 - DOI - PMC - PubMed
1. Davey M. Huge study supporting ivermectin as Covid treatment withdrawn over ethical concerns. Available: https://www.theguardian.com/science/2021/jul/16/huge-study-supporting-iv...